Andrew Zhu, MD, PhD | Authors

Articles

Advice on Decision Making for Frontline Treatment of HCC

September 21, 2018

Andrew Zhu, MD, PhD, director of Liver Cancer Research and Medicine at Massachusetts General Hospital, shares his advice on making decisions for frontline treatment of patients with hepatocellular carcinoma.